OS Therapies Inc
Grasonville, MD · Founded 2018 · CIK 0001795091 · Biotech · Public
HER2-targeted cancer immunotherapy for osteosarcoma and solid tumors
ostherapies.com →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- $30M
- 11 Form D · Aug 2026
- 2 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓201920202021202220232024202520262027
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $359,000 | |
| Private capital raised | Form D · SEC | $5,000,000 | |
| Private capital raised | Form D · SEC | $1,000,000 | |
| Private capital raised | Form D · SEC | $2,000,000 | |
| Private capital raised | Form D · SEC | $700,000 | |
| Private capital raised | Form D · SEC | $7,103,000 | |
| Private capital raised | Form D · SEC | $4,216,794 | |
| Private capital raised | Form D · SEC | $3,777,808 | |
| Private capital raised | Form D · SEC | $3,498,650 | |
| Private capital raised | Form D · SEC | $2,000,000 | |
| Private capital raised | Form D · SEC | $5,000,000 |
Form D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1213 | Novoglia, Inc. | — | $37M |
| 1214 | Matrubials, Inc. | — | — |
| 1215 | MADRIGAL PHARMACEUTICALS, INC. | — | $35M |
| 1216 | OS Therapies Inc | — | $30M |
| 1217 | Universal Ibogaine Inc. | — | $135K |
| 1218 | Willowcroft Pharm Inc | — | $5.0M |
| 1219 | Valanbio Therapeutics Inc | — | $121K |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Christopher AcevedoExecutive Officer
- Joacim BorgDirector
- John CiccioDirector
- Gerald CommissiongExecutive Officer
- Karim GalzahrDirector
- Colin GoddardDirector
- Olivier JarryDirector
- Avril McKean DieserDirector
- Robert PetitExecutive Officer
- Paul RomnessDirector · Executive Officer · Promoter
- Theodore SearchDirector
- Jutta WannerExecutive Officer
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.